Notice of Privacy Incident
Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.

Drugs and Therapeutics (D & T) Committee September 17, 2014

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Otezla	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Hemangeol	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Opsumit	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Orenitram ER	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Mycamine	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Requirement Removed
Ambisome	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Requirement Removed
Brilinta	PDL Appeal	Require Prior Approval	Prior Approval Required

Footer